Nilsine Partners’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Nilsine Partners's NVS Position: Q3 2026 in Review
Nilsine Partners reduced its Novartis (NVS) stake by 3.5% in Q3 2026, selling an estimated $25.3K and leaving 4,642 shares worth $662K. The position accounts for 0.05% of the portfolio, ranked #285.
Nilsine Partners first reported a position in NVS in Q1 2023 and has held it in 15 quarters since. The position peaked at $965K in Q3 2023. 1,561 funds tracked by Wall St. Rank hold NVS as of Q3 2026.
- Nilsine Partners held 4,642 shares of Novartis worth $662K as of Q3 2026.
- Nilsine Partners sold 167 Novartis shares in Q3 2026, an estimated $25.3K.
- Novartis made up 0.05% of Nilsine Partners's portfolio in Q3 2026, its #285 holding.
- Nilsine Partners first reported a position in Novartis in Q1 2023 and has held it in 15 quarters since.
- Nilsine Partners's Novartis position peaked at $965K in Q3 2023.
- 1,561 funds tracked by Wall St. Rank held Novartis as of Q3 2026.
Based on Nilsine Partners's 13F filing for Q3 2026, filed 2 Nov 2026.